Brainstorm Cell Theraputc (BCLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,614 | -10,388 | -5,059 | -24,277 | -19,259 |
| Depreciation Amortization | 199 | 134 | 67 | 285 | 215 |
| Accounts receivable | N/A | -341 | N/A | 1,067 | N/A |
| Other Working Capital | -537 | -1,502 | 1,002 | 2,990 | 3,067 |
| Other Operating Activity | -5,221 | 1,333 | 4 | 615 | 1,305 |
| Operating Cash Flow | $-17,173 | $-10,764 | $-3,986 | $-19,320 | $-14,672 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,015 | 2,009 | 2,005 | 1,027 | -11 |
| PPE Investments | -18 | N/A | N/A | -29 | -29 |
| Investing Cash Flow | $1,997 | $2,009 | $2,005 | $998 | $-40 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15,626 | 8,529 | 3,230 | 238 | N/A |
| Financing Cash Flow | $15,626 | $8,529 | $3,230 | $238 | $N/A |
| Beginning Cash Position | 772 | 772 | 772 | 18,856 | 18,856 |
| End Cash Position | 1,222 | 546 | 2,021 | 772 | 4,144 |
| Net Cash Flow | $450 | $-226 | $1,249 | $-18,084 | $-14,712 |
| Free Cash Flow | |||||
| Operating Cash Flow | -17,173 | -10,764 | -3,986 | -19,320 | -14,672 |
| Capital Expenditure | -18 | N/A | N/A | -29 | -29 |
| Free Cash Flow | -17,191 | -10,764 | -3,986 | -19,349 | -14,701 |